Researchers at the University of Liverpool have discovered how a protein linked to a severe form of childhood epilepsy is positioned within nerve cells, shedding new light on a rare genetic neurological disorder, according to a university news release.
The condition, known as CDKL5 deficiency disorder (CDD), causes severe epilepsy beginning in early infancy along with significant developmental difficulties. It is estimated to occur in approximately 1 in 40,000 to 60,000 live births worldwide. The disorder is caused by mutations in the CDKL5 gene, which produces a protein essential for normal brain development and function.
Although scientists have known about the CDKL5 protein for years, relatively little has been understood about how it works inside nerve cells and why mutations cause such profound neurological problems. The new research, led by Professor of Mechanistic Cell Biology Ben Goult, provides a framework for understanding how CDKL5 functions and how mutations might disrupt brain development, the university reported.
A key finding is the identification of a previously unrecognised molecular docking mechanism that attaches CDKL5 to the structural framework of synapses — the junctions where nerve cells communicate. This discovery reveals how CDKL5 is positioned at synapses, something that had remained unclear despite years of research into the protein.
According to the research, the positioning of CDKL5 within nerve cells is equally critical as its function. The alteration of the newly identified anchoring system caused changes in nerve cell organization, underscoring the essential role this placement plays in healthy brain activity.
Dr Yasumi Otani, first author of the study and a former PhD student in the Institute of Systems, Molecular and Integrative Biology, said in the release: “What was particularly striking was that changing just a single amino acid at the very end of CDKL5 was enough to dramatically alter its localisation in nerve cells. This shows just how critical the final residues of the protein are for keeping CDKL5 in the right place at synapses.”
A direct link was discovered between CDKL5 and the cell's mechanical systems. The researchers observed that CDKL5 attaches to talin, a protein that alters its form when physical forces are applied. In lab-grown cells, experiments revealed that blocking this attachment or lowering the forces produced by the cell changed the location of CDKL5. This points to a previously unknown mechanism where mechanical forces might affect where CDKL5 functions.
These results have the potential to change how scientists view the connection between disease-causing CDKL5 mutations and neurological issues. Many mutations responsible for CDKL5 deficiency disorder make the protein shorter, eliminating the identified docking region. Yet these findings indicate that some mutations might cause harm not just by altering the protein itself, but also by stopping it from reaching the right spot inside nerve cells.
Professor Goult said: “Much of the research into CDKL5 deficiency disorder has focused on the activity of the enzyme itself. Our work highlights another potentially crucial factor: where that activity takes place. By identifying the molecular interactions that position CDKL5, we can begin to understand how the protein is organised within synapses and why disrupting this organisation might interfere with communication between nerve cells.”
Andreas Borg, founder of CURE5, a parent-led foundation dedicated to finding a cure for CDKL5 deficiency disorder, said: “Seeing how profoundly CDKL5 loss affects so many systems in the body also gives us hope that new opportunities for therapeutic intervention remain to be discovered. The new understanding of the protein’s location and function identified in this work opens up one such possibility. As parents, even the smallest improvements in our children’s lives mean the world.”
Scientists from the University of Helsinki, Finland, partnered on this study. The findings appeared in Science Advances under the title ‘Cyclin-dependent kinase-like 5 (CDKL5) binds talin and is anchored at the postsynaptic density by direct PDZ interactions’..
For university students studying biomedical sciences, neuroscience, or genetics, this research illustrates how fundamental cell biology — specifically the study of protein localisation and mechanical forces within cells — can directly inform the understanding of a rare disease. It also highlights the growing importance of mechanobiology, a field that examines how physical forces influence cellular function, which may become increasingly relevant in future medical research and therapeutic development.